Login / Signup

A two-pronged attack against mantle cell lymphoma.

Christian Steidl
Published in: Blood (2015)
In this issue of Blood, Bhatt et al describe direct cytotoxic and indirect immune cell-mediated effects of interleukin-21 (IL-21) in mantle cell lymphoma (MCL), providing a preclinical rationale for IL-21 therapy in this aggressive disease.
Keyphrases
  • cell therapy
  • clinical trial
  • stem cells
  • mesenchymal stem cells
  • bone marrow